The effectiveness and tolerability of pharmacotherapy for psychosis in 22q11.2 Deletion Syndrome: A systematic review.
Article in Australian & New Zealand Journal of Psychiatry (February 2024)
The most recent citing publications are shown below. View all 11 publications that cite this research output on Dimensions.
Metyrosine treatment in a woman with chromosome 22q11.2 deletion syndrome and psychosis: a case study
Article in International Journal of Developmental Disabilities (November 2017)
The Effectiveness and Safety of Antipsychotic and Antidepressant Medications in Individuals with 22q11.2 Deletion Syndrome
Article in Journal of Child and Adolescent Psychopharmacology (July 2015)